Here's where markets stand at mid-day:
-NYSE down 8.29 (-0.1%) to 8,264.28
-DJIA down 4.04 (-0.03%) to 12,037.93
-S&P 500 down 1.13 (-0.09%) to 1,303.10
-Nasdaq up 2.90 (+0.1%) to 2,752.44
Hang Seng up 1.8%
Nikkei down 0.25%
FTSE down 0.28%
MID-DAY NYSE INDEX WATCH
NYSE Energy down 0.83% at 13,491.46
NYSE Financial down 0.15% at 5,205.21
NYSE Health Care down 0.08% at 6,570.89
NYSE Arca Tech 100 up 0.17% at 1,135.42
(+) HNSN (+39.24%) inks fiber optic deal.
(+) GMCR (+16.1%) continues evening gain that followed upbeat
(+) BJ (+13%) weighing alternatives, including sale.
(+) MRNA (+9.6%) reports bladder cancer development
(+) SCON (+8.2%) continues early week gain on new product.
(+) GSK (+2.8%) swings to loss but sets buyback.
(+) FRG (+38.8%) sold to Newmont.
(+) NLST (+28.2%) reports Intel server compatibility.
(-) CVI (-2.6%) prices stock offering.
(-) OTIV (-2.2%) prices stock offering.
(-) MRK (-2.6%) beats with earnings but disappoints with
(-) CVS (-6.6%) beats by a penny but guidance straddles Street
(-) RDN (-2.5%) reports wider-than-expected loss.
(-) ISIL (-12.9%) continues evening slide that followed Q4 miss,
(-) ENTR (-1.5%) continues evening gain that followed upbeat
Stocks are near even at mid-day, as investors decipher the
latest government employment data, which showed a drop in weekly
jobless claims that erased most of the increase in the prior week's
data. Meanwhile, concern over new violence in Egypt weighed on
generally positive corporate earnings and retailer's same-store
Before the bell, new data from the Labor Department showed
weekly jobless claims fell 42,000 to 415,000 with the four-week
moving average rising 1,000 to 430,500.
Also, factory orders rose 0.2% in December, much stronger than
the 0.4% decline expected by economists. This is the fifth increase
in the past six months. Orders for durable goods fell 2.3% in
December, better than the 2.5% drop estimated a week ago,
Marketwatch.com reports. Orders for nondurable goods offset this
weakness, rising 2.3% in the month.
In company news:
GlaxoSmithKline plc (
) and Theravance, Inc. (
) reported progress in two clinical development programs focused on
new treatments for chronic obstructive pulmonary disease patients.
The companies initiated Phase III program for the once-daily
LAMA/LABA dual bronchodilator GSK573719/vilanterol, among other
progress made. GlaxoSmithKline shares are up 2.62% to trade at
$37.95 last check.
) shares are down as Reuters reports the US refiner said that a
fire last month at the company's 58,000 barrel per day refinery in
North Dakota had a minimal impact on production. The refinery has
reportedly run beyond its planned rates and repairs are expected to
finished in March, the report said.
) and Verizon (
) shares are down even as the two begin taking pre-orders for the
iPhone designed for use with the Verizon Wireless network. The move
marks the end of AT&T's (T) exclusive contract with Apple to
sell the iPhone.
Merck & Company Inc. (MRK) shares are down after the drug
maker reported it swung to a loss in Q4 of $531 million, or 17
cents a share, from a year-earlier profit of $6.94 billion, or
$2.35 a share. But adjusted earnings in the quarter were 88 cents a
share, higher than the Street consensus forecast of 83 cents. Also,
Bloomberg reported that the company's vaccine for preventing the
HPV in women also reduces the rate of infection in men, according
to a study in the New England Journal of Medicine.
Wells Fargo & Co. (WFC) is just higher as Bloomberg reports
the bank is planning to withdraw money from its hedge-fund firm,
Overland Advisors, which is seeking new investors. Wells is
responding to US limitations on bank risk taking. The bank will
withdraw $150 million every quarter until the first half of 2014,
the report said.
ADRs of Royal Dutch Shell (RDS.A) are down as the European oil
major reported earnings that came short of what analysts were
expecting. Shell earned $4.1 billion in the fourth quarter
excluding one-time items and inventory charges. That came short of
the $4.7 billion analysts had predicted for the refiner, according
to a survey of analysts compiled by Bloomberg.
In retail sales:
--J. C. Penney (JCP) today posted its comparable store sales for
the four-week period ended Jan. 29, which decreased 1.2%. Strong
sales during the first two months of the quarter resulted in
quarterly sales coming in above the company's expectations,
according to the company.
--Nordstrom (JWN) reported that for January, its
comparable-store sales saw an increase of 4.8% while total sales
increased 11.8% to $607 million.
--Ross Stores (ROST) says January same-store sales grew 3%. Q4
sales were $2.145 billion, more than the Thomson Reuters mean for
--Gap (GPS) reported its January 2011 net sales increased 6%
compared with last year.
--Saks (SKS) reported that its sales totaled $163.6 million for
the four weeks ended January 29, 2011 compared to $158.9 million
for the four weeks ended January 30, 2010, seeing a 3% increase.
Comparable store sales were up 4.4% for the month.
--Kohl's (KSS) reported that its January sales rose 3.4%
compared to the same period in 2010. On a comparable store basis,
January sales increased 1.4%. For the full year, total sales
increased 7.1% and comparable store sales increased 4.4%.
In other earnings news:
--AutoNation (AN) announced that its fourth-quarter net income
increased 9% on stronger sales of new vehicles.
--Blackstone Group (BX) says Q4 sales rose to $1.084015 billion
from a year ago. Net loss was $0.03 per common unit.
--MasterCard (MA) reports Q4 EPS of $3.16 per share, better than
the analyst consensus of $3.04 per share on Thomson Reuters.
Revenue was $1.4 bln, in line with expectations.
--Kellogg (K) says Q4 sales were $2.9 billion, above the Thomson
Reuters mean for $2.85 billion. It earned a net $0.51 per share,
--ADRs of Sony Corp. (SNE) are higher after the company posted
an operating profit of 137.52 billion yen or $1.68 billion compared
with an average estimate of 127 billion yen in a poll of eight
analysts by Thomson Reuters.
--Visa Inc. (V) is down after reporting its 2011 Q1 net income
came in at $884 million, or $1.23 per share. That compares to net
income of $763 million, or $1.03 per share, a year earlier. Net
operating revenue was $2.2 billion, up 14% from the prior-year
period driven by strong double-digit growth in service revenues,
data-processing revenues and international transaction revenues.
Analysts were expecting profit of $1.20 a share and revenue of
$2.22 billion, according to FactSet.
--MasterCard (MA) shares are down after the credit card network
reported fourth quarter earnings per share of $3.16, which is
better than the analyst consensus of $3.04 per share on Thomson
Reuters. Revenue was $1.4 billion, in line with expectations.
Commodities are mixed. April gold contracts are up $4, or 0.32%,
to $1,337 an ounce while March crude oil contacts are down 0.24%,
or $0.22, at $90.62 a barrel.
In energy ETFs, the United States Oil Fund (USO) is down 0.08%
to $38.16 and the United States Natural Gas fund (UNG) is down
1.59% to $5.89.
In precious metal ETFs, the SPDR Gold Trust (GLD) is up 0.96% to
$131.74. Market Vectors Gold Miners (GDX) is up 1.71% to $56.01.
iShares Silver Trust (SLV) is up 0.98% to $27.96.